NeuPath Health (TSXV:NPTH) Debt-to-Equity : 0.55 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is NeuPath Health Debt-to-Equity?

NeuPath Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$1.33 Mil. NeuPath Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$10.79 Mil. NeuPath Health's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$22.05 Mil. NeuPath Health's debt to equity for the quarter that ended in Dec. 2023 was 0.55.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for NeuPath Health's Debt-to-Equity or its related term are showing as below:

TSXV:NPTH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.46 Med: 0.64 Max: 2.02
Current: 0.55

During the past 5 years, the highest Debt-to-Equity Ratio of NeuPath Health was 2.02. The lowest was 0.46. And the median was 0.64.

TSXV:NPTH's Debt-to-Equity is ranked worse than
54.11% of 547 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs TSXV:NPTH: 0.55

NeuPath Health Debt-to-Equity Historical Data

The historical data trend for NeuPath Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuPath Health Debt-to-Equity Chart

NeuPath Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

2.02

0.46

0.64

0.65

0.55

NeuPath Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.65	0.62	0.63	0.54	0.55

Competitive Comparison of NeuPath Health's Debt-to-Equity

For the Medical Care Facilities subindustry, NeuPath Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeuPath Health's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NeuPath Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where NeuPath Health's Debt-to-Equity falls into.

NeuPath Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

NeuPath Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.327	+	10.793)	/	22.054
	=	0.55

NeuPath Health's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.327	+	10.793)	/	22.054
	=	0.55

NeuPath Health (TSXV:NPTH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

NeuPath Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of NeuPath Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuPath Health (TSXV:NPTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NeuPath Health Inc (TSXV:NPTH) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

181 Bay Street, Suite 2100, Toronto, ON, CAN, M5J 2T3

Website

https://www.neupath.com

NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.

NeuPath Health (TSXV:NPTH) Headlines

No Headlines